SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-026769
Filing Date
2023-08-02
Accepted
2023-08-02 16:15:18
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gthx-20230630.htm   iXBRL 10-Q 1009038
2 EX-10.2 gthx-20230630xex102.htm EX-10.2 27069
3 EX-31.1 gthx-20230630xex311.htm EX-31.1 10849
4 EX-31.2 gthx-20230630xex312.htm EX-31.2 10914
5 EX-32.1 gthx-20230630xex321.htm EX-32.1 5620
6 EX-32.2 gthx-20230630xex322.htm EX-32.2 5684
12 gthx-20230630_g1.jpg GRAPHIC 8623
  Complete submission text file 0001628280-23-026769.txt   5846464

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gthx-20230630.xsd EX-101.SCH 47581
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gthx-20230630_cal.xml EX-101.CAL 49171
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gthx-20230630_def.xml EX-101.DEF 218756
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gthx-20230630_lab.xml EX-101.LAB 562022
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gthx-20230630_pre.xml EX-101.PRE 370292
65 EXTRACTED XBRL INSTANCE DOCUMENT gthx-20230630_htm.xml XML 700263
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 231135777
SIC: 2834 Pharmaceutical Preparations